Developer docs
API playgroundTry for free, no card

Search company profiles

TechAccel

Full company profile

uuid0009xkf

Namestring
TechAccel
Legal namestring
TechAccel LLC
Websiteurl
techaccel.net
Company typeenum
Private
Founded yearint
2014
Descriptiontext

TechAccel LLC is a privately held technology and venture development company founded in 2014 in Overland Park, Kansas, that sources, funds, and advances early-stage innovations in agriculture, animal health, and food technology. It operates an "Equity + Science Advancement" model in which it deploys sponsored research, technical due-diligence, and equity capital into startups, university spinouts, and licensable platform technologies, then advances those assets toward commercial milestones for acquisition or return to a strategic partner's portfolio. The firm has built relationships with 25+ universities including UC Davis, Kansas State, Iowa State, University of Missouri, and the Donald Danforth Plant Science Center, and holds seven Master Research Agreements supporting faculty consultancy and pre-commercial research.

TechAccel's proprietary technology stack centers on RNA interference (RNAi) for low-cost bioprocessed RNA and biopesticides, MSH1 epigenetic technology licensed from Penn State through portfolio company Epicrop Technologies, and gene editing for disease-resistant crops. These platforms are commercialized through wholly-owned subsidiary RNAissance Ag LLC — which operates RNAi-based insecticides targeting diamondback moth, fall armyworm, and White spot syndrome virus in shrimp — and through two joint ventures with Epicrop, EpiBerry and EpiCanola, focused on berry and canola crops. The firm also retains equity positions in a portfolio that includes Benson Hill (gene editing and machine-learning crop design, went public via SPAC), Agrivida (GRAINZYME feed enzymes), GreenLight Biosciences (RNA manufacturing), Plastomics (chloroplast transgene stacking), Sound Agriculture, and Locus Biosciences (acquired TechAccel-funded EpiBiome in 2017).

Monetization combines professional services revenue (sponsored university research, consulting, and stage-gate program management), licensing and royalty streams from portfolio and licensed IP, and equity-driven returns from portfolio exits — exemplified by the 2021 sale of a 70% stake in Covenant Animal Health Partners to NovaQuest Capital Management. Customers and partners are global agribusiness strategics, animal-health companies, food-technology firms, and venture capital firms that co-invest alongside TechAccel. Headcount is approximately 30–40, supported by offices and lab space in Overland Park and a 2,000-square-foot fermentation-and-manufacturing facility at BRDG Park on the Donald Danforth Plant Science Center campus in St. Louis.

Short descriptiontext

TechAccel is a privately held technology and venture development firm founded in 2014 in Overland Park, Kansas, that invests equity and sponsors research to advance early-stage agriculture, animal-health, and food-technology innovations from universities and startups to commercial milestones for strategic acquisition or licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersShawnee Mission, United States
HQ citystring
Shawnee Mission
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
agricultural biotechnology, animal health ventures, venture development services, science advancement research, crop improvement technology
Industry3 codes
PRIMARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAE
Process Development & Tech Transfer (Upstream/Downstream/MSAT)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Agricultural Biotechnology Venture Development
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Equity Investments in Startups
TypeLicensing Royalties
Description

TechAccel makes equity investments in high-potential agriculture, animal health, and food tech startups, deploying capital and scientific expertise to advance platforms toward commercialization

techaccel.net
2Science Advancement Services
TypeProfessional Services
Description

Science advancement and de-risking research services provided to universities, strategics, and portfolio companies; sponsors research at universities to advance and de-risk portfolio technologies

techaccel.net
3University Technology Consulting
TypeProfessional Services
Description

Contracts university faculty as consultants for investment due diligence activities and research scoping

techaccel.net
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1RNAissance Ag
Description

Ag biotechnology startup developing novel RNAi-based insecticides for control of destructive pests such as diamondback moth and fall armyworm.

techaccel.net
+2 more records
Core offering1 text field

TechAccel is a technology and venture development company that sources breakthrough innovations from universities, global strategics, and startups, advancing them through de-risking research and equity investment. The firm deploys capital and scientific expertise into early-stage agriculture, animal health, and food technology platforms, then transfers the de-risked assets to strategic acquirers or back to investor portfolios. Its portfolio includes RNAi biopesticide subsidiary RNAissance Ag and epigenetic crop joint ventures EpiBerry and EpiCanola.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Up to 20-29% yield advantage in tomatoes and 30-35% in sorghum under stress conditions from epigenetic technology
+1 more record
Product overview1 text field

TechAccel is a technology and venture development company that invests in, acquires, and advances early-stage technologies in the agriculture, animal health, and food technology sectors. The company's core offering is its Science Advancement Services, which focuses on platform technologies sourced from start-ups, universities, and industry. TechAccel operates through subsidiaries including RNAissance Ag (RNAi-based insecticides), EpiBerry and EpiCanola (joint ventures for epigenetic crop enhancement), and maintains equity relationships with portfolio companies like Benson Hill, Agrivida, Epicrop Technologies, GreenLight Biosciences, Plastomics, and Sound Agriculture.

Product and service4 records
1RNAissance Ag
CategoryCrop Protection Biotechnology
Description

Biotechnology subsidiary developing novel RNAi-based insecticides (including sprayable RNAi products) targeting destructive pests such as diamondback moth and fall armyworm. Aimed at agricultural input providers and farmers seeking targeted alternatives to conventional insecticides.

2EpiBerry
CategoryEpigenetic Crop Technology
Description

Joint venture with Epicrop Technologies applying MSH1-based epigenetic trait selection to enhance growth and stress resilience in berry crops without altering DNA sequence.

3EpiCanola
CategoryEpigenetic Crop Technology
Description

Joint venture with Epicrop Technologies applying MSH1-based epigenetic trait selection to enhance growth and stress resilience in canola without altering DNA sequence.

4Science Advancement Services
CategoryVenture Development and R&D Services
Description

Core service offering that identifies breakthrough scientific innovations from universities, startups, and global strategics, then advances them through de-risking research and stage-gate project management to commercial milestones. Designed for universities, strategic partners, and portfolio startups seeking capital plus scientific expertise to bridge the gap from laboratory discovery to market.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

RNAissance Ag (TechAccel subsidiary) acquired assets of RNAgri LLC, a St. Louis-based startup, adding manufacturing capabilities.

2Wells Fargo Innovation Incubator (IN2)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

RNAissance Ag was selected as part of the first agtech cohort in the Wells Fargo Innovation Incubator (IN2) program.

techaccel.net
3Donald Danforth Plant Science Center
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Path To Commercialization Program providing up to $250,000 in grants for proof-of-concept studies. TechAccel co-located its science team at BRDG Park on the Danforth Center campus.

techaccel.net
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TechAccel-sponsored research in development of heat-tolerant and drought-resistant wheat. TechAccel has licensed the intellectual property and is funding science advancement.

5University of California, Davis
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Since 2016, TechAccel has participated in the Venture Catalyst STAIR-Plus program supporting commercialization milestones. In 2018, TechAccel invested in expansion of Venture Catalyst STAIR grants.

techaccel.net
Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of 25+ universities in TechAccel's strategic network for innovation sourcing and research advancement in agriculture and plant science.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Part of strategic university network for de-risking and advancement research in agriculture and animal science.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

International university partner in TechAccel's research network for agriculture and food technology innovation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

TechAccel invested in Epicrop and formed joint ventures EpiBerry (for berries) and EpiCanola (for canola) to advance epigenetic technology for enhanced crop growth.

10Reliance Animal Health Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-founded Covenant Animal Health Partners in 2018 with TechAccel for development of animal health products.

techaccel.net
Strategic tierMinorTypeStrategic or Co-development Partner
Description

In 2017, Locus acquired TechAccel-funded EpiBiome, a microbiome engineering firm, for its bacteriophage discovery platform.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Corteva (via Corteva Catalyst and its open-innovation programs) invests in and partners with agtech startups in gene editing, biologicals, and digital agriculture, comparable to TechAccel's portfolio strategy.

TypeEmerging player
Description

GreenLight Biosciences is both a TechAccel portfolio company and a peer developing low-cost bioprocessed RNA, sharing the same core RNA-manufacturing platform that powers RNAissance Ag.

TypeEmerging player
Description

Inari Agriculture is an ag-biotech company using AI and biological engineering to develop high-performance seeds, overlapping with TechAccel's investments in gene editing, epigenetics, and computational biology for crop improvement.

TypeEmerging player
Description

Pivot Bio is an emerging ag-biotech company developing microbial nitrogen-fixing products as alternatives to synthetic inputs, competing for the same biological-inputs category of ag innovation that TechAccel targets with its RNAi and epigenetic platforms.

5Leaps by Bayer
TypeBroad incumbent
Description

Leaps by Bayer is the corporate venture arm of Bayer, investing in breakthrough agricultural and life-science platforms with similar technologies (gene editing, RNAi, biologicals) to TechAccel's portfolio focus.

TypeEmerging player
Description

Benson Hill is a TechAccel portfolio company (Series A and B investor) that is now a publicly traded crop improvement company using gene editing and machine learning, representing both a successful exit validation and a technology peer in plant genomics.

7Syngenta Ventures
TypeBroad incumbent
Description

Syngenta Ventures is the corporate venture capital arm of Syngenta Group, deploying capital into agtech and crop science startups, overlapping directly with TechAccel's RNAi, gene editing, and trait-discovery focus areas.

TypeBroad incumbent
Description

ADM Ventures invests across agtech, food tech, and animal health, providing strategic partnership pathways for portfolio companies similar to the exit optionality TechAccel offers to its portfolio.

TypeDirect peer
Description

Fall Line Capital is a thesis-driven venture firm that invests in and actively advances early-stage agtech companies, making it one of the closest direct peers to TechAccel's venture development model in agriculture and animal health.

TypeDirect peer
Description

Cultivian Sandbox is an agtech-focused venture fund that combines venture capital with operating expertise to scale early-stage agricultural innovations, closely mirroring TechAccel's hybrid science-advancement-plus-equity thesis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment11 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TechAccel

Agricultural Biotechnology Venture Developmenttechaccel.net

TechAccel is a privately held technology and venture development firm founded in 2014 in Overland Park, Kansas, that invests equity and sponsors research to advance early-stage agriculture, animal-health, and food-technology innovations from universities and startups to commercial milestones for strategic acquisition or licensing.

What TechAccel does

TechAccel LLC is a privately held technology and venture development company founded in 2014 in Overland Park, Kansas, that sources, funds, and advances early-stage innovations in agriculture, animal health, and food technology. It operates an "Equity + Science Advancement" model in which it deploys sponsored research, technical due-diligence, and equity capital into startups, university spinouts, and licensable platform technologies, then advances those assets toward commercial milestones for acquisition or return to a strategic partner's portfolio. The firm has built relationships with 25+ universities including UC Davis, Kansas State, Iowa State, University of Missouri, and the Donald Danforth Plant Science Center, and holds seven Master Research Agreements supporting faculty consultancy and pre-commercial research.

TechAccel's proprietary technology stack centers on RNA interference (RNAi) for low-cost bioprocessed RNA and biopesticides, MSH1 epigenetic technology licensed from Penn State through portfolio company Epicrop Technologies, and gene editing for disease-resistant crops. These platforms are commercialized through wholly-owned subsidiary RNAissance Ag LLC — which operates RNAi-based insecticides targeting diamondback moth, fall armyworm, and White spot syndrome virus in shrimp — and through two joint ventures with Epicrop, EpiBerry and EpiCanola, focused on berry and canola crops. The firm also retains equity positions in a portfolio that includes Benson Hill (gene editing and machine-learning crop design, went public via SPAC), Agrivida (GRAINZYME feed enzymes), GreenLight Biosciences (RNA manufacturing), Plastomics (chloroplast transgene stacking), Sound Agriculture, and Locus Biosciences (acquired TechAccel-funded EpiBiome in 2017).

Monetization combines professional services revenue (sponsored university research, consulting, and stage-gate program management), licensing and royalty streams from portfolio and licensed IP, and equity-driven returns from portfolio exits — exemplified by the 2021 sale of a 70% stake in Covenant Animal Health Partners to NovaQuest Capital Management. Customers and partners are global agribusiness strategics, animal-health companies, food-technology firms, and venture capital firms that co-invest alongside TechAccel. Headcount is approximately 30–40, supported by offices and lab space in Overland Park and a 2,000-square-foot fermentation-and-manufacturing facility at BRDG Park on the Donald Danforth Plant Science Center campus in St. Louis.

TechAccel firmographics

Firmographics
Name
TechAccel
Legal name
TechAccel LLC
Website
https://techaccel.net
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
TechAccel is a privately held technology and venture development firm founded in 2014 in Overland Park, Kansas, that invests equity and sponsors research to advance early-stage agriculture, animal-health, and food-technology innovations from universities and startups to commercial milestones for strategic acquisition or licensing.
Ownership category
akta.pro rank

TechAccel industry classification

Industry
Product category
Agricultural Biotechnology Venture Development
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAE
Process Development & Tech Transfer (Upstream/Downstream/MSAT)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Agricultural biotechnology
  • Animal health ventures
  • Venture development services
  • Science advancement research
  • Crop improvement technology

Where TechAccel is headquartered

Location

Headquarters

HQ city
Shawnee Mission
HQ country
United States
HQ region
North America

Offices2 records

Markets served

TechAccel business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Equity Investments in Startups: TechAccel makes equity investments in high-potential agriculture, animal health, and food tech startups, deploying capital and scientific expertise to advance platforms toward commercialization
  2. Science Advancement Services: Science advancement and de-risking research services provided to universities, strategics, and portfolio companies; sponsors research at universities to advance and de-risk portfolio technologies
  3. University Technology Consulting: Contracts university faculty as consultants for investment due diligence activities and research scoping

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

TechAccel product offering

Product offering

Core offering

TechAccel is a technology and venture development company that sources breakthrough innovations from universities, global strategics, and startups, advancing them through de-risking research and equity investment. The firm deploys capital and scientific expertise into early-stage agriculture, animal health, and food technology platforms, then transfers the de-risked assets to strategic acquirers or back to investor portfolios. Its portfolio includes RNAi biopesticide subsidiary RNAissance Ag and epigenetic crop joint ventures EpiBerry and EpiCanola.

Product overview

TechAccel is a technology and venture development company that invests in, acquires, and advances early-stage technologies in the agriculture, animal health, and food technology sectors. The company's core offering is its Science Advancement Services, which focuses on platform technologies sourced from start-ups, universities, and industry. TechAccel operates through subsidiaries including RNAissance Ag (RNAi-based insecticides), EpiBerry and EpiCanola (joint ventures for epigenetic crop enhancement), and maintains equity relationships with portfolio companies like Benson Hill, Agrivida, Epicrop Technologies, GreenLight Biosciences, Plastomics, and Sound Agriculture.

Differentiator

Problem solved

Functional benefit

Brands

  • RNAissance Ag: Ag biotechnology startup developing novel RNAi-based insecticides for control of destructive pests such as diamondback moth and fall armyworm.
  • EpiBerry
  • EpiCanola

Products and services

  • RNAissance Ag Biotechnology subsidiary developing novel RNAi-based insecticides (including sprayable RNAi products) targeting destructive pests such as diamondback moth and fall armyworm. Aimed at agricultural input providers and farmers seeking targeted alternatives to conventional insecticides.
  • EpiBerry Joint venture with Epicrop Technologies applying MSH1-based epigenetic trait selection to enhance growth and stress resilience in berry crops without altering DNA sequence.
  • EpiCanola Joint venture with Epicrop Technologies applying MSH1-based epigenetic trait selection to enhance growth and stress resilience in canola without altering DNA sequence.
  • Science Advancement Services Core service offering that identifies breakthrough scientific innovations from universities, startups, and global strategics, then advances them through de-risking research and stage-gate project management to commercial milestones. Designed for universities, strategic partners, and portfolio startups seeking capital plus scientific expertise to bridge the gap from laboratory discovery to market.

Quantifiable outcome

  • Up to 20-29% yield advantage in tomatoes and 30-35% in sorghum under stress conditions from epigenetic technology
  • +1 more outcomes

Companies that use TechAccel

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles4 records

TechAccel technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

TechAccel partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor and core.

  • RNAgriminorStrategic or Co-development Partner · 1 January 2020RNAissance Ag (TechAccel subsidiary) acquired assets of RNAgri LLC, a St. Louis-based startup, adding manufacturing capabilities.
  • Wells Fargo Innovation Incubator (IN2)coreStrategic or Co-development Partner · 1 January 2019RNAissance Ag was selected as part of the first agtech cohort in the Wells Fargo Innovation Incubator (IN2) program.
  • Donald Danforth Plant Science CentercoreStrategic or Co-development PartnerStrategic partnership with Path To Commercialization Program providing up to $250,000 in grants for proof-of-concept studies. TechAccel co-located its science team at BRDG Park on the Danforth Center campus.
  • Kansas State UniversitycoreStrategic or Co-development PartnerTechAccel-sponsored research in development of heat-tolerant and drought-resistant wheat. TechAccel has licensed the intellectual property and is funding science advancement.
  • University of California, DaviscoreStrategic or Co-development PartnerSince 2016, TechAccel has participated in the Venture Catalyst STAIR-Plus program supporting commercialization milestones. In 2018, TechAccel invested in expansion of Venture Catalyst STAIR grants.
  • University of MissouricoreStrategic or Co-development PartnerOne of 25+ universities in TechAccel's strategic network for innovation sourcing and research advancement in agriculture and plant science.
  • Iowa State UniversitycoreStrategic or Co-development PartnerPart of strategic university network for de-risking and advancement research in agriculture and animal science.
  • Swansea UniversitycoreStrategic or Co-development PartnerInternational university partner in TechAccel's research network for agriculture and food technology innovation.
  • Epicrop TechnologiescoreStrategic or Co-development PartnerTechAccel invested in Epicrop and formed joint ventures EpiBerry (for berries) and EpiCanola (for canola) to advance epigenetic technology for enhanced crop growth.
  • Reliance Animal Health PartnerscoreStrategic or Co-development PartnerCo-founded Covenant Animal Health Partners in 2018 with TechAccel for development of animal health products.
  • Locus BiosciencesminorStrategic or Co-development PartnerIn 2017, Locus acquired TechAccel-funded EpiBiome, a microbiome engineering firm, for its bacteriophage discovery platform.

Scale indicators4 records

Recent moves11 records

Expansion highlights6 records

TechAccel competitors and assessment

Company assessment

Broad incumbents

  • Corteva Catalyst: Corteva (via Corteva Catalyst and its open-innovation programs) invests in and partners with agtech startups in gene editing, biologicals, and digital agriculture, comparable to TechAccel's portfolio strategy.
  • Leaps by Bayer: Leaps by Bayer is the corporate venture arm of Bayer, investing in breakthrough agricultural and life-science platforms with similar technologies (gene editing, RNAi, biologicals) to TechAccel's portfolio focus.
  • Syngenta Ventures: Syngenta Ventures is the corporate venture capital arm of Syngenta Group, deploying capital into agtech and crop science startups, overlapping directly with TechAccel's RNAi, gene editing, and trait-discovery focus areas.
  • ADM Ventures: ADM Ventures invests across agtech, food tech, and animal health, providing strategic partnership pathways for portfolio companies similar to the exit optionality TechAccel offers to its portfolio.

Emerging players

  • GreenLight Biosciences: GreenLight Biosciences is both a TechAccel portfolio company and a peer developing low-cost bioprocessed RNA, sharing the same core RNA-manufacturing platform that powers RNAissance Ag.
  • Inari Agriculture: Inari Agriculture is an ag-biotech company using AI and biological engineering to develop high-performance seeds, overlapping with TechAccel's investments in gene editing, epigenetics, and computational biology for crop improvement.
  • Pivot Bio: Pivot Bio is an emerging ag-biotech company developing microbial nitrogen-fixing products as alternatives to synthetic inputs, competing for the same biological-inputs category of ag innovation that TechAccel targets with its RNAi and epigenetic platforms.
  • Benson Hill: Benson Hill is a TechAccel portfolio company (Series A and B investor) that is now a publicly traded crop improvement company using gene editing and machine learning, representing both a successful exit validation and a technology peer in plant genomics.

Direct peers

  • Fall Line Capital: Fall Line Capital is a thesis-driven venture firm that invests in and actively advances early-stage agtech companies, making it one of the closest direct peers to TechAccel's venture development model in agriculture and animal health.
  • Cultivian Sandbox: Cultivian Sandbox is an agtech-focused venture fund that combines venture capital with operating expertise to scale early-stage agricultural innovations, closely mirroring TechAccel's hybrid science-advancement-plus-equity thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

TechAccel social profiles

Digital presence

TechAccel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TechAccel leadership team

Management profile

Number of profiles

Profiles15 records

TechAccel subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

TechAccel funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TechAccel M&A and investment

M&A and investment

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TechAccel

What does TechAccel do?

TechAccel is a technology and venture development company that sources breakthrough innovations from universities, global strategics, and startups, advancing them through de-risking research and equity investment. The firm deploys capital and scientific expertise into early-stage agriculture, animal health, and food technology platforms, then transfers the de-risked assets to strategic acquirers or back to investor portfolios. Its portfolio includes RNAi biopesticide subsidiary RNAissance Ag and epigenetic crop joint ventures EpiBerry and EpiCanola.

Is TechAccel a public or private company?

TechAccel is a private company. It is classified as venture growth investor backed and is currently operating.

When was TechAccel founded?

TechAccel was founded in 2014. It employs 11 to 50 people.

Where is TechAccel based?

TechAccel is headquartered in Shawnee Mission, United States, in the North America region.

How does TechAccel make money?

Three revenue lines are on record. Equity Investments in Startups are the primary driver. The others are science Advancement Services and university Technology Consulting.

Who are TechAccel's main competitors?

Broad incumbents on record are Corteva Catalyst, Leaps by Bayer, Syngenta Ventures and ADM Ventures. Emerging players are GreenLight Biosciences, Inari Agriculture, Pivot Bio and Benson Hill. Direct peers are Fall Line Capital and Cultivian Sandbox.

Does TechAccel have an API?

No public API is recorded for TechAccel.

What industry is TechAccel in?

TechAccel's product category is Agricultural Biotechnology Venture Development. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO), with a secondary code of HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconprairienewsKansas State University president joins TechAccel board of directorsKansas State University president Dr. Richard H. Linton joined TechAccel's board of directors effective immediately. TechAccel, a Kansas-based venture development organization, was founded in 2014 with K-State support. Linton brings experience in food science and agriculture to the board.Business Wire BlogNovaQuest Capital Management Acquires TechAccel’s Interest In Covenant Animal Health PartnersNovaQuest Capital Management acquired TechAccel's ownership stake in Covenant Animal Health Partners, a partnership formed in 2018. The investment expands NovaQuest's development universe and supports innovation in animal health. Covenant will advance new assets into industry partner portfolios.PrivateequitywireNovaQuest Capital Management acquires TechAccel’s interest in Covenant Animal Health PartnersNovaQuest Capital Management has acquired TechAccel’s ownership stake in Covenant Animal Health Partners, a product development partnership originally formed by TechAccel and Reliance Animal Health Partners. This transaction allows NovaQuest to expand its development universe in the animal health sector while enabling Covenant to leverage new resources for advancing revenue-ready assets.AgFunderNewsTechAccel subsidiary RNAissance Ag acquires RNAgri to boost manufacturing capacityTechAccel's RNAissance Ag acquired RNAgri to boost RNA production capacity for RNAi biopesticides. The company plans field trials this summer targeting Diamondback Moth and Fall Armyworm, with a $10 billion market by 2025. It will invest in production and R&D, aiming to expand St. Louis facilities.TechaccelStunning growth in Ag Biotech Market investments – Tech AccelTechAccel reports ag biotech investment doubled to $6.9 billion across 385 companies in 2019, up from $3.4 billion in 245 companies in 2017. The growth occurred despite a negative agricultural cycle and trade tariffs. Plant biotech attracted the most new entries, with over 20 startups.FinSMEsTechAccel Launches RNAissance Ag; Invests in GreenLight BiosciencesTechAccel launched RNAissance Ag, holding an exclusive license to RNAi technology with the Danforth Plant Science Center for sprayable insect control. The company also invested in GreenLight Biosciences, which raised a $50 million Series round for biopesticide development.SiliconprairienewsTechAccel announces investment in plant biotechnology startup Plastomics Inc.TechAccel completed a science advancement investment with Plastomics, a St. Louis-based chloroplast engineering startup. The funding will accelerate Plastomics' technology and a new chloroplast-expressed insect control trait collaboration, with terms undisclosed. Plastomics had recently closed an early seed round with BioGenerator and The Yield Lab.FinSMEsPlastomics Receives Science Advancement Investment from TechAccelPlastomics, a St. Louis-based chloroplast engineering biotech, received a science advancement investment from TechAccel, amount undisclosed. The funds will accelerate its technology development and a new chloroplast-expressed insect control trait collaboration. The company also recently closed an early seed round with BioGenerator and The Yield Lab.AgFunderNewsTechAccel Backs Chloroplast Engineering Startup PlastomicsTechAccel backed St. Louis-based Plastomics, a startup developing chloroplast engineering to shorten seed development pipelines. The investment funds a science advancement initiative and a new insect control trait collaboration. Plastomics aims to demonstrate corn regeneration via chloroplasts this year.AgFunderNewsAg Biotech Market Map: 245 Startups Using Biology & Chemistry to Revolutionize AgricultureTechAccel released a market map analyzing 245 ag biotech startups, highlighting that the sector raised $262 million in the first half of the year and has accumulated approximately $3.4 billion in total funding since 1995. The report categorizes these companies into key areas including gene editing, breeding technologies, cloud biology, animal health, and microbiome research to guide venture investment strategies.